Oncology in Spain

Dr. Eduardo Castañón Álvarez, a highly regarded oncology specialist at Clínica Universidad de Navarra in Pamplona, Spain, brings a wealth of experience and unwavering clinical expertise to his practice. With six years in the field, Dr. Castañón Álvarez is recognized for his proficiency in diagnosing neoplasms and providing comprehensive treatment for various oncological lesions affecting the body. Notably, he holds ESMO MORA certification, reflecting his commitment to the highest standards of oncological care. Dr. Castañón Álvarez's educational journey includes a bachelor's degree in medicine from Navarra University in 2009, followed by specialization in oncology at the same institution until 2015. During this period, he earned the title of Doctor of Medicine. His dedication to continuous learning is evident through his internship at the Gustave Roussy Institute, where he focused on trials conducted by the DITEP group from 2015 to 2017. Additionally, he holds a master's degree in biostatistics and molecular oncology. In his professional career, Dr. Castañón Álvarez has emerged as a key figure in the oncology sector at Navarra Hospital, maintaining his association with the institute since 2015. He also holds prominent roles as a leading professor at Navarra University and the MIR academy. Actively engaged in the academic and research community, he is associated with prestigious societies and organizations, including the Spanish (SEOM), American (ASCO), and European (ESMO) cancer societies. Furthermore, he contributes to cancer research on an international scale as a member of the American (AACR) and European (EORTC) cancer research organizations. Dr. Eduardo Castañón Álvarez's notable achievements extend beyond his clinical practice, with participation in over 50 communications at global conferences and co-authorship of eight books aimed at students specializing in the field. His research contributions include the publication of 38 articles in globally recognized journals, showcasing his commitment to advancing oncological knowledge and treatment strategies.

Dr. Javier Aristu, the Clinical Director of the Proton Therapy Unit at Clínica Universidad de Navarra in Spain, brings over 25 years of expertise in oncology to his role. Specializing in Radiation Oncology, Dr. Aristu demonstrates a particular focus on radiosurgery, cranial and extracranial stereotactic radiotherapy, and intensity-modulated radiotherapy. His extensive skills encompass cancer therapy, radiotherapy, surgical oncology, and advanced techniques such as PET-CT and PET-MRI. Notably, he has a successful track record in interventions for lung cancer utilizing cyberknife technology. With a commitment to personalized treatment plans, priority appointments, and a dedicated medical coordinator, Dr. Aristu ensures comprehensive and cutting-edge care for his patients.

Dr. Jesús Corral is a top oncologist in Spain, widely recognized for his expertise in chemotherapy and radiotherapy for thoracic, digestive, and genitourinary cancers. With over 15 years of medical and academic excellence, he has held senior roles in some of the most prestigious cancer institutions in Spain, including the Clínica Universidad de Navarra and Jerez University Hospital. His distinguished background also includes fellowships at MD Anderson in Houston and the Royal Marsden in London. As the President of the Andalusian Society of Medical Oncology (SAOM), he plays a vital role in advancing cancer research and training in Spain, making him a leading cancer specialist in Spain. His work in lung cancer and gene expression studies has shaped new standards in personalized cancer treatment, earning him national acclaim as one of the best oncologists in Spain.

Dr. Jesús Damaso Aquerreta Beola, a distinguished specialist in radio diagnosis, has made significant contributions to the field with over 15 years of dedicated experience. Currently serving as the Head of the Conventional Radiology and Muscle Radiology Division at the University of Navarra Clinic in Spain, Dr. Aquerreta Beola has established himself as a prominent figure in the realm of oncology. His educational journey includes graduating in medicine and surgery from the University of Navarra Clinic, followed by obtaining a specialization certificate in radiology from the same institution. Dr. Aquerreta Beola's professional trajectory began with a residency in MRI of the skeletal muscle system at Ohio University Hospital, USA. Subsequently appointed as a radiology specialist at the University of Navarra Clinic, he ascended to the role of Director of the Conventional Radiology and Skeletal Muscle Radiology Department. Additionally, he contributes to academia as an adjunct professor in the Department of Radiology at the University of Navarra Clinic. His active involvement extends to memberships in esteemed organizations, including the Spanish Community of Medical Radiology, European Federation of Radiology, Spanish Organization of Musculoskeletal Radiology, and the Establishment of Radiologists of Navarra. Dr. Aquerreta Beola's passion for research is evident in his areas of interest, focusing on treatment techniques for tumors in the skeletal muscle system. His extensive research contributions are reflected in over 130 articles published in national and international journals, co-authorship of more than 15 books, and participation in 14 doctoral theses. Recognized for his outstanding achievements, Dr. Aquerreta Beola has received accolades such as the Extraordinary Doctorate Award from the University of Navarra Clinic and the SECOT Award for orthopedic research. Notably, his articles have garnered approximately 720 citations, underscoring the impact of his work in the field of radio diagnosis and oncology.

Dr. Leire Arbea Moreno stands out as one of the top Radiation Oncologists in Spain, with over 25 years of extensive experience. Based at the prestigious Clínica Universidad de Navarra, she is recognized for her groundbreaking work in radiation therapy and medical education. Dr. Arbea Moreno earned her medical degree and specialization in Radiation Oncology from the University of Navarra and pursued advanced education with a Master’s in Molecular Oncology from CNIO. Known as a famous Spanish radiation oncologist, she is celebrated not just for her clinical expertise but also for her remarkable contributions to medical education. She has received multiple accolades, including the Lilly Medical Education Chair Award for Best Teaching Practice and distinguished recognition for her thesis on IMRT radiotherapy. Currently serving as Vice-Dean of Educational Innovation and Director of the Medical Education Unit, she actively shapes the future of healthcare professionals. With a career deeply rooted in academic excellence, clinical mastery, and innovation, Dr. Leire Arbea Moreno is one of the most respected and leading figures in oncology in Spain.

Dr. Lucía Ceniceros Paredes, an esteemed professional in the fields of Oncology, Gastroenterology, and Digestive Oncology, is recognized both nationally and internationally for her contributions to medical research. With a commitment to advancing therapeutic procedures, her focus encompasses neoadjuvant chemotherapy, radiation therapy, targeted and immunotherapy, as well as biological therapies. Actively engaged in scientific exploration, Dr. Ceniceros Paredes has participated in approximately 20 clinical trials, seeking optimal ways to prevent and treat pathologies affecting abdominal organs and systems. Her dedication extends to enhancing the accuracy of disease diagnosis methods. Educated at the University of Navarra, Dr. Ceniceros Paredes completed her medical degree in 2011 and pursued specialization at the same institute, culminating in certification as an oncologist by SEOM in 2018. Committed to continuous learning, she underwent further training at the Royal Marsden Hospital in London and the Centro Integral Oncológico Clara Campal. A distinguished professor at Navarra University, Dr. Ceniceros Paredes has played a pivotal role in training resident students and is recognized as an innovative force in the new generation of doctors at Navarra Hospital. Active in key medical organizations, Dr. Lucía Ceniceros is a member of prominent societies such as the Spanish Society of Medical Oncology (SEOM) and the European Society for Medical Oncology (ESMO). Her significant contributions include authoring five international scientific publications, with research papers focusing on Immunotoxicity in Immunotherapy.

Dr. Miguel Fernández de Sanmamed Gutiérrez is a leading medical oncologist in Spain, affiliated with the prestigious Clínica Universidad de Navarra and the Cima Universidad de Navarra. He currently serves as the Principal Investigator of the Onco-Applied and Translational Immunology Group, as well as Co-Coordinator of the Skin Tumor Area at the University of Navarra Cancer Center. With a strong academic foundation and international exposure, Dr. Sanmamed has trained at renowned institutions including Yale University and Stanford University, enriching his global perspective on cancer research and treatment. Recognized for his excellence, Dr. Sanmamed was named a Highly Cited Researcher in 2023 by Web of Science, highlighting his impact in the oncology field. With over 70 scientific publications and multiple awards from leading cancer research societies such as ESMO and AECC, he stands among the top cancer specialists in Spain. His dedication to cancer research and education is reflected in his active teaching roles at the University of Navarra and Yale School of Medicine. As a famous oncologist in Spain, his work continues to inspire the next generation of cancer researchers and physicians.

Dr. Salvador Martin Algarra, a distinguished Medical Oncologist at Clínica Universidad de Navarra, also holds the position of Professor of Oncology at the Medical School of the University of Navarra in Pamplona, Spain. With an illustrious career, he obtained his Doctorate in Medicine and Surgery from the University of Navarra in 1985, following which he specialized in Medical Oncology in 1991. Dr. Martin Algarra furthered his expertise through a clinical fellowship in Oncology/Hematology at the University of Nebraska Medical Center in Omaha, USA. Dr. Martin Algarra has played pivotal roles in the medical field, serving as a member of the Directive Board of Clínica Universidad de Navarra and holding positions such as President of its Educational Board, Director of the Department of Oncology, and co-director of the Cell Therapy Area at the University of Navarra. His current focus lies in the therapeutic development of immunotherapy and targeted therapies, particularly in melanoma, sarcoma, and rare tumors. Dr. Martin Algarra is a founding member and the current President of the Spanish Melanoma Group (GEM). Engaged in extensive research, he has participated in 48 research projects and acted as the Leading Investigator for 43 of them, with a primary interest in melanoma and sarcomas of unknown origin. As an educator, Dr. Martin Algarra imparts his knowledge through teaching responsibilities at the University of Navarra Faculty of Medicine, contributing significantly to undergraduate and graduate education in Medical Oncology. His prolific research contributions include 90 publications in indexed journals, 29 of which are in the first tertile, and active participation in numerous conferences and scientific committees. Dr. Martin Algarra's expertise encompasses a wide range of oncological areas, making him a key figure in advancing cancer research and treatment.